Dan Leonard
Stock Analyst at UBS
(1.59)
# 1483
Out of 5,343 analysts
287
Total ratings
48.98%
Success rate
8.11%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MTD Mettler-Toledo Intl | Upgrades: Buy | 1530 1350 | 1135.42 | 18.9% | 9 | May 20, 2025 | |
TXG 10x Genomics | Maintains: Neutral | 14 12 | 8.54 | 40.52% | 5 | May 13, 2025 | |
TECH Bio-Techne | Maintains: Buy | 95 70 | 47.29 | 48.02% | 11 | May 9, 2025 | |
BRKR Bruker | Maintains: Neutral | 57 45 | 36.34 | 23.83% | 11 | May 8, 2025 | |
IQV IQVIA Hldgs | Maintains: Buy | 255 185 | 137.99 | 34.07% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 355 310 | 227.41 | 36.32% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 65 70 | 37.08 | 88.78% | 9 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 145 115 | 90.44 | 27.16% | 2 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 715 500 | 400.03 | 24.99% | 15 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 275 240 | 187.44 | 28.04% | 14 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 29 25 | 12.86 | 94.4% | 7 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 250 185 | 135.45 | 36.58% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 9 | 6.23 | 44.46% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 420 350 | 293.08 | 19.42% | 1 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 16 16 | 11.48 | 39.37% | 9 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 35 | 20.56 | 70.23% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 160 150 | 109.74 | 36.69% | 20 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 225 200 | 80.55 | 148.29% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 11 | 2.29 | 380.35% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 70 | 152.5 | -54.1% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 75 90 | 56.45 | 59.43% | 9 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Underperform | 7 | 8.84 | -20.81% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 160 | n/a | n/a | 12 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 345 | 348.01 | -0.86% | 12 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 260 | 126.87 | 104.93% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 1 | n/a | n/a | 3 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 160 145 | 169.51 | -14.46% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 95 90 | 54.48 | 65.2% | 12 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 62 64 | 42.31 | 50.44% | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 330 340 | 241.92 | 40.54% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 24 | 22.62 | 6.1% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 4 2 | n/a | n/a | 3 | May 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 45 35 | 3.94 | 788.32% | 11 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 80 55 | n/a | n/a | 3 | May 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Hold | 18 0 | n/a | n/a | 3 | May 7, 2018 |